AI-Driven CT Innovations from 4DMedical Transform COPD Diagnosis and Patient Care

As COPD continues to grow as a global health burden—predicted by the World Health Organization (WHO) to become the third leading cause of death by 2030—innovative AI-driven medical imaging technologies are rapidly advancing diagnosis, staging, and treatment. In a recent Radiology Today article, “Breathing Room,” writer Beth W. Orenstein explores how clinicians are increasingly relying on advanced CT imaging solutions.

Price Transparency and Radiology: A Necessity for Better Patient Care

Price Transparency and Radiology

Recent findings published in the Journal of the American College of Radiology highlight a concerning trend: high out-of-pocket costs for imaging procedures can delay necessary medical diagnoses, potentially impacting patient outcomes. This underscores the critical role of price transparency in radiology.

Regional Lung Volume Changes with Non-Invasive Positive Pressure Ventilation in Healthy Adults

Regional Lung Volume Changes with Non-Invasive Positive Pressure Ventilation in Healthy Adults

This study highlights the potential of using XV, an advanced functional imaging tool, to better understand regional lung function and optimize the therapeutic application of Non-Invasive Positive Pressure Ventilation (NIPPV). These insights could pave the way for improved patient outcomes for individuals with respiratory conditions, by tailoring interventions to improve their lung function. The ability to non-invasively visualize and measure these regional changes marks a substantial advancement for both clinicians and researchers involved in respiratory care, potentially transforming treatment strategies and patient management.

How Coronary Artery Calcification Predicts Heart Health

Coronary artery calcification is a strong indicator of heart health and potential heart attack risk. The calcification aspect refers to the collection of calcium in your heart’s two main arteries (the coronary arteries). These arteries are responsible for pumping blood to the rest of the body. A well-functioning heart also ensures that blood circulates efficiently through the lungs, facilitating effective gas exchange.

Innovation, Partnerships—for Lung Health and Veterans: Philips and 4DMedical

Innovation, Partnerships—for Lung Health and Veterans: Philips and 4DMedical

Industry leaders Jeff DiLullo, Executive Vice President and Chief Region Leader of Philips North America, and Prof. Andreas Fouras, Managing Director and Chief Executive Officer of 4DMedical, led a transformative session at the annual RSNA conference. The session discussed how the partnership between the two companies aims to enhance healthcare accessibility for Veterans; it highlighted collaborative efforts to improve cardiothoracic imaging and address the unique needs of Veterans, particularly those exposed to airborne toxins.

DoD to conduct Paid CT:VQ™ Pilot Ahead of FDA Submission

CT-VQ – A Better Pulmonary Perfusion Test

4DMedical has won a contract with the United States Department of Defense (DoD) to pilot its CT Ventilation-Perfusion (CT:VQ™) technology to assess lung health in a fixed cohort of active duty personnel.

This contract builds on the success of 4DMedical’s earlier agreement with the DoD for the deployment of its CT Lung Ventilation Analysis Software (CT LVAS™) in a clinical pilot program. The new arrangement reflects the DoD’s recognition of the utility and impact of 4DMedical’s technology in delivering critical health insights for active military personnel. The contracted arrangement with the DoD is best characterized as a commercial pilot, involving the delivery of a fixed number of scan analysis reports on full commercial terms.

4DMedical Receives U.S. FDA Clearance for IQ-UIP™

IQ-UIP FDA Clearance

4DMedical has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ-UIP™ product, an advanced AI-driven lung diagnostic tool designed to revolutionize the diagnosis of Usual Interstitial Pneumonia (UIP), the hallmark radiological pattern for diagnosing Interstitial Pulmonary Fibrosis (IPF).

4DMedical Unveils CT:VQ™ at RSNA 2024

4DMedical Limited unveiled its innovative CT:VQ technology at RSNA 2024, offering a revolutionary alternative to traditional Nuclear VQ scans, aiming to enhance diagnostic capabilities in lung health. The new imaging solution eliminates the use of radioactive isotopes, streamlining procedures while improving patient access…

The Imaging Wire Show — Getting Virtual with 4DMedical

4DMedical highlighted its unique technology for imaging respiratory function at the RSNA 2024 meeting. And the company is using a novel virtual reality environment to demonstrate its XV Scanner, as we learn in this Imaging Wire Show interview by Brian Casey with Greg Mogel, MD, and Tom Harris.

4DMedical Wins Three-Year Commercial Contract with UCSD Health

UCSC Commercial Contract

4DMedical has been awarded a contract with US-based Imaging Partners of Orange County (IPOC) to provide computed tomography (CT) scans for lung ventilation (LVAS) and lung density (LDAf) analysis.

The contract – the term of which extends through March, 2026 – reflects accelerated progress in the commercialisation of 4DMedical’s lung imaging technology and provides IPOC with scan analysis services on a subscription basis per patient, billed quarterly.